Zhaoke Ophthalmology (HKSE:06622) Change In Receivables : HK$0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Zhaoke Ophthalmology Change In Receivables?

Zhaoke Ophthalmology's change in receivables for the quarter that ended in Dec. 2024 was HK$0.00 Mil. It means Zhaoke Ophthalmology's Accounts Receivable stayed the same from Jun. 2024 to Dec. 2024 .

Zhaoke Ophthalmology's change in receivables for the fiscal year that ended in Dec. 2024 was HK$-5.60 Mil. It means Zhaoke Ophthalmology's Accounts Receivable increased by HK$5.60 Mil from Dec. 2023 to Dec. 2024 .

Zhaoke Ophthalmology's Accounts Receivable for the quarter that ended in Dec. 2024 was HK$1.47 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Zhaoke Ophthalmology's Days Sales Outstanding for the six months ended in Dec. 2024 was 12.87.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Zhaoke Ophthalmology's liquidation value for the six months ended in Dec. 2024 was HK$914.15 Mil.

Zhaoke Ophthalmology Change In Receivables Historical Data

The historical data trend for Zhaoke Ophthalmology's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhaoke Ophthalmology Change In Receivables Chart

Zhaoke Ophthalmology Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

-19.54

-19.31

-30.89

16.15

-5.60

Zhaoke Ophthalmology Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Change In Receivables	Get a 7-Day Free Trial						-	-	-	-	-

Zhaoke Ophthalmology Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.00 Mil.

Zhaoke Ophthalmology (HKSE:06622) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Zhaoke Ophthalmology's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	1.472	/	20.878	*	91
=	12.87

2. In Ben Graham's calculation of liquidation value, Zhaoke Ophthalmology's accounts receivable are only considered to be worth 75% of book value:

Zhaoke Ophthalmology's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	1271.769	-	366.679	+	0.75 * 1.472	+	0.5 * 15.909
=	914.15

Zhaoke Ophthalmology Change In Receivables Related Terms

Thank you for viewing the detailed overview of Zhaoke Ophthalmology's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhaoke Ophthalmology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhaoke Ophthalmology Ltd (HKSE:06622) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

9FX:Germany

Address

No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangdong Province, Guangzhou, CHN

Website

https://www.zkoph.com

Zhaoke Ophthalmology Ltd is an ophthalmic pharmaceutical company. It is dedicated to the research, development, and commercialization of therapies that address unmet medical needs in China. The company has built a comprehensive ophthalmic drug pipeline of 26 candidates that covers ocular indications affecting the front and the back of the eye, through either in-house development or in-licensing. It has also established an ophthalmic manufacturing facility and is assembling an experienced marketing team in anticipation of a near-term product launch.

Executives

Mak Siu Hang Viola	2201 Interest of corporation controlled by you
Gic Private Limited	2201 Interest of corporation controlled by you
Apstar Investment Pte Ltd	2201 Interest of corporation controlled by you
Coyote Investment Pte Ltd	2101 Beneficial owner
Gic (ventures) Pte. Ltd.	2201 Interest of corporation controlled by you
Gic Special Investments Private Limited	2102 Investment manager
Fidelity China Special Situations Plc	2101 Beneficial owner
Fil Limited	2201 Interest of corporation controlled by you
Pandanus Associates Inc.	2201 Interest of corporation controlled by you
Pandanus Partners L.p.	2201 Interest of corporation controlled by you
Citigroup Inc.	2502 Approved lending agent
Vms Holdings Limited	2201 Interest of corporation controlled by you
Lee's Pharmaceutical Holdings Limited	2201 Interest of corporation controlled by you
Tpg Asia Genpar Vii, L.p.	2201 Interest of corporation controlled by you
Tpg Holdings Iii-a, L.p.	2201 Interest of corporation controlled by you

Zhaoke Ophthalmology Headlines

No Headlines